Top 20 Pharma’s R&D Spending Topped $86 billion in 2009

Pharmaceutical companies remain on an upward R&D trend through 2010. More than 9,000 new drugs have been added to the pipeline this year, showing growth in all clinical stages of development. The pharmaceutical and biotech industriestop 20 pipeline leaders spent a combined $86.57 billion during 2009. Several leading pharmaceutical companies have implemented large-scale and aggressive M&A strategies.Editors of PharmaLive.com, a leading source for pharmaceutical business, marketing, and clinical research information, have released the second annual Top 20 Pipelines Special Report.

READ MORE OF THIS ARTICLE AT: http://www.drugs.com/news/top-20-pharma-s-r-amp-d-spending-topped-86-billion-2009-28542.html

Veröffentlicht unter Around the Globe
JOIN TODAY!
The P/P Registry has been approved by the Western Institutional Review Board (WIRB) and is actively enrolling participants.

ENGLISH VERSION

SPANISH VERSION